Faruk H. Örge MD, FAAO, FAAP, has been a part of our department since 2007 and serving as the Vice Chair of Clinical Affairs, Director and the Fellowship Director of Pediatric Ophthalmology and Adult Strabismus. After completing a research fellowship for 2 years, an internship, residency, and a clinical fellowship in Indiana University he opted to return to his country to serve as an academician. He joined Yeditepe University School of Medicine Department of Ophthalmology, Istanbul/Turkey as an Assistant Professor. There he helped to initiate the efforts on building not only the ophthalmology department but also an eye hospital and affiliated two clinics and formed one of the prominent dedicated pediatric ophthalmology divisions in Turkey. Since he has joined our institution in 2007, he has excelled as an educator and clinician along with his administrative activities in our department. After joining his division as the Associate Director he was promoted to be the Co-Director in 2009 and as the Director in 2010 of the Pediatric Ophthalmology and Adult Strabismus Service, a center of excellence in our Eye Institute. Dr. Örge was named the William R. and Margaret E. Althans Chair and Professor in Pediatric Ophthalmology in 2012.
Dr Örge is seeing patients with all aspects of eye diseases in pediatric population along with simple and complex childhood and adult strabismus (misalignment of the eyes). He is recognized as one of the best clinicians regionally, and his remarkable skills allowed his nomination to be listed in the Best Doctors of America list in the first year he has joined our ranks and been listed ever since; He was also added to the Top Doctors list. His passion to his patients and his profession has been contagious and he has been receiving complicated patient referral from not only the local pediatricians, optometrists and ophthalmologists, but also from pediatric ophthalmology peers locally as well as out of state, and internationally. His particular interest in pediatric glaucoma has allowed him to be one of the most able clinicians in this field. He has pioneered surgical interventions and was the first in the nation to successfully perform endoscopic goniotomy in more than 5 patients, and first in the region to apply techniques such as endoscopic cyclophotocoagulation, and 360 degree trabeculotomy. A recognition of his clinical excellence in part led him to receive a generous $1 million gift from the Althans foundation. This was matched by the Board of Rainbow Babies and Children’s Hospital by another $500,000 and an Althans Endowed Chair in pediatric ophthalmology was recently established.
Dr. Orge sees patients at UH Rainbow Babies and Children’s Hospital as well as our Landerhaven, and Westlake satellites.
He has been not only active in teaching locally but has been receiving international fellows to expand the pediatric ophthalmology knowledge worldwide. He is also serving in the American Association of Pediatric Ophthalmology and Strabismus Public Information Committee (committee’s main purpose is to educate public in pediatric ophthalmology related issues and understand the different ophthalmic problems in pediatric population), and the Professional Education Committee. As the Chair of the Social Media Committee he has initiated periodic online live international courses. He is a holder of the medical Educators Education Course Certificate, which he received this through a hands on course in Yeditepe University School of Medicine. The best example of his dedication to medical education was his award of the coveted Attending of the Year Award by the resident election in 2010.
American Board of Ophthalmology - Ophthalmology
Education & Training
Medical / Professional School(s)
1996, Trakya Universitesi
2001, General Surgery - Indiana University Hospital
2004, Ophthalmology - Indiana University Hospital
2005, Pediatric Ophthalmology - Indiana University Hospital
2000, Ophthalmology - Indiana University Hospital
Adult Strabismus, Children's Eyes, Comprehensive Ophthalmology, Crossed Eyes, Droopy Eyelid, Pediatric Cataract, Pediatric Glaucoma, Sports Injuries, Childhood Strabismus, Retinopathy of Prematurity, Lazy Eye (Amblyopia)
UH Westlake Health Center
950 Clague Rd
UH Eye Institute, Bldg B, Ste 102
UH Eye Institute
6001 Landerhaven Dr
Landerhaven Office Plaza, Ste B
UH Case Medical Center
Department of Ophthalmology
11100 Euclid Ave
His dedication to research and clear direction resulted him being awarded grants including prestigious Knights Templar Eye Foundation Research Grant for his project in retinopathy of prematurity (ROP), Cleveland Foundation grants (New glaucoma device formation, suture sterilization, resident microsurgery course assessment) through Minimally Invasive Pediatric Surgery Center, Rainbow research awards, CWRU PFI Funding (for I-Strab Objective Strabismus Measurement Device), Ohio Amblyope Registry (An organization that fights amblyopia in state level) and UH Innovation day award for his new designed eye speculum. Since he has joined our faculty, pediatric ophthalmology research has bloomed in not only at a local level (within the division as well as combined research with neonatology, neurology, neurosurgery, oncology, etc), but also regionally (is the Co-PI for the design and evaluation of a ROP screening device in collaboration with NASA, Case, UH and RB&C; A member of Ohio Amblyope Registry); nationally (NEI funded PEDIG – pediatric eye disease investigation group, has finished 2 and is leading 6 studies with this group; pharmaceutical studies with Alcon, Bausch and Laumb). He currently has many projects running regarding almost all aspects of pediatric ophthalmology (ROP, glaucoma, microsurgery, cataract, genetic conditions, lid trauma, consultation, sedation, strabismus, nystagmus, amblyopia, etc).
Dr. Örge is involved regionally and nationally in his field. He gave lectures in the Cleveland Ophthalmological Society meetings in the last 4 years. He has presented more than 50 papers in AAO, AAPOS, ARVO, Pediatric meetings, as well as international meetings (World Pediatric ophthalmology congress, International Strabismus Association, National Turkish Ophthalmic Society meetings). Due to his activities in the AAPOS, he was invited as the youngest member for the Long Range Planning Retreat. This retreat is gathered every 4-5 years, with only 14 selected members (6 past presidents) to set future direction of the organization.
Dr. Örge is recognized as a young future leader. He was among the recently chosen group for the University Hospitals Leadership Development Program to better his leadership skills and completed his training last year.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Faruk Orge, MD did not disclose any Outside Relationships with Industry.